Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07638046 · ClinicalTrials.gov registry record · Phase 2

Mindful Walking Neural Correlates of Executive Function in SC Older Adults at Risk of Dementias

A Phase 2 study, sponsored by University of South Carolina.

Recruiting
Registry status
Phase 2
Development phase
54
Enrollment target

NCT07638046: Recruiting Phase 2 study, sponsored by University of South Carolina.

NCT07638046 is a Phase 2 study that is actively recruiting participants, run by University of South Carolina. The registered enrollment target is 54 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07638046, a Phase 2 study, is actively recruiting participants, sponsored by University of South Carolina.

RECRUITING
Registry status
Phase 2
Development phase
54 participants
Enrollment target

Study Summary

Mindful walking is a promising and practical strategy because it combines two activities known to support healthy aging: walking and mindfulness. Unlike many structured exercise programs, mindful walking is low intensity, accessible, and easier to sustain in daily life. It may be especially useful for older adults at elevated risk for ADRD. However, most existing mindful walking studies have focused on mental health outcomes, such as stress reduction, rather than cognitive health. Little is known about whether mindful walking can support cognition or how it may influence brain function. To address this gap and strengthen a future R01 resubmission, the investigators propose a two-arm randomized controlled pilot trial using functional near-infrared spectroscopy (fNIRS), a safe, non-invasive brain imaging method. fNIRS measures brain activity through sensors placed on the scalp and is well-suited for repeated assessments in older adults because it is quiet, portable, painless, and cost-effective. The investigators will recruit racially and ethnically diverse middle-aged and older adults from the Midlands of South Carolina who are at elevated risk for ADRD. Participants will be randomly assigned to one of two groups: mindful walking or walking-only control. Both groups will complete 8 staff-supervised individual sessions over 4 weeks. The mindful walking group will learn and practice simple mindfulness skills while walking in multiple settings, including lab-based, indoor, and outdoor environments, to support real-world use. Findings from this pilot study will provide important evidence on whether mindful walking can support brain and cognitive health in adults at elevated risk for ADRD. The results will also help establish a practical, scalable, and sustainable prevention strategy for underserved aging populations in South Carolina.

Primary Outcome

Hemodynamic activation in the prefrontal and parietal regions as an indication of EF. Neural activation will be measured using functional nearinfrared spectroscopy (fNIRS).

Interventions

  • BEHAVIORAL Mindfulness-based walking
  • BEHAVIORAL Walking-only

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2026-06-26
Est. Completion 2027-11-17
Phase Phase 2
University of South Carolina

157 total trials

What NCT07638046 shows while recruiting

NCT07638046 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (59% lower).

The record links to 0 conditions, and to 2 interventions - of which Mindfulness-based walking is the first listed.

NCT07638046 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07638046 about?

NCT07638046 is a clinical study titled "Mindful Walking Neural Correlates of Executive Function in SC Older Adults at Risk of Dementias". Mindful walking is a promising and practical strategy because it combines two activities known to support healthy aging: walking and mindfulness. Unlike many structured exercise programs, mindful walking is low intensity, accessible, and easier to sustain in daily life. It may be especially useful f...

What is the current status of trial NCT07638046?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2026-06-26. Estimated completion is 2027-11-17.

What interventions are being tested in trial NCT07638046?

The interventions under investigation include: Mindfulness-based walking (BEHAVIORAL), Walking-only (BEHAVIORAL).

Who is sponsoring clinical trial NCT07638046?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07638046's enrollment target sits among peer trials

54 1160th of 2000 higher than 830 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01269853 · 54 participants · Phase 1

    Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

  • NCT02390752 · 54 participants · Phase 1

    Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

  • NCT02991248 · 54 participants · NA

    Improve Dynamic Lateral Balance of Humans With SCI

  • NCT02993900 · 54 participants · NA

    Image-Guided Gynecologic Brachytherapy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07638046, the US trial registry maintained by the National Library of Medicine. NCT07638046 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.